Edward Graves
Publication Details
-
Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.
Int J Radiat Oncol Biol Phys. 2002; (5): 1254-64
The role of radiotherapy (RT) seems established for patients with low-grade gliomas with poor prognostic factors. Three-dimensional (3D) magnetic resonance spectroscopy imaging (MRSI) has been reported to be of value in defining the extent of glioma infiltration. We performed a study examining the impact MRSI would have on the routine addition of 2-3-cm margins around MRI T2-weighted hyperintensity to generate the treatment planning clinical target volume (CTV) for low-grade gliomas.
Help
Trial Administration